Engineering targeted nanomedicines for advanced prostate cancer

• Κύριος συγγραφέας: Bahlool, Ahmad
• Άλλοι συγγραφείς: Κλεπετσάνης, Παύλος
• Μορφή: Thesis
• Γλώσσα: English
• Έκδοση: 2020
• Θέματα: Prostate cancer; Nanomedicines; Liposomes; Nanoparticles; Targeted therapy; Καρκίνος προστάτη; Νανοϊατρική; Λιποσώματα; Νανοσωματίδια; Στοχευμένη θεραπεία

Prostate cancer is one of the most common types of cancer. Prostate cancer treatment protocols include the use of androgen deprivation therapy (ADT) and docetaxel which have high resistance rate in advanced disease stages. XD19 is a novel compound showed a promising activity on C4-2B prostate cancer...